Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion type Assertion NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_head.
- NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion description "[By using two different approaches, namely the recombinant endostatin protein and the gene therapy strategy, our study demonstrated that endostatin could be effective in suppressing the growth of human FTC in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_provenance.
- NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion evidence source_evidence_literature NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_provenance.
- NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion SIO_000772 12193566 NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_provenance.
- NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion wasDerivedFrom befree-2016 NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_provenance.
- NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_assertion wasGeneratedBy ECO_0000203 NP365465.RAZ_wc2qZ9BgntlJ60Ef-pdbv416MY_Mzxfl8hCvPQL78130_provenance.